Reps. Tim Murphy (R-PA) and Earl Blumenauer (D-OR) Friday introduced the Overdose Prevention and Patient Safety Act (H.R. 3545), AHA-supported legislation that would align Part 2 federal regulations governing the confidentiality of substance use disorder treatment records with the Health Insurance Portability and Accountability Act to ensure patients with substance use disorders receive the integrated care they need. A coalition of more than 30 health care stakeholder organizations, including the AHA, voiced support for the bill. “Hospitals and health systems see first-hand every day the devastating effects of substance use disorders, including opioid addiction, on patients, families and communities,” said AHA Executive Vice President Tom Nickels. “Congress passed measures providing critical resources to communities battling the epidemic last year, however, to ensure comprehensive treatment more needs to be done to allow for the appropriate sharing of patient substance use records. We thank Congressmen Tim Murphy and Earl Blumenauer for introducing this important bipartisan legislation, and we look forward to working with Congress to enact it.”

Headline
The AHA provided comments to the Medicare Payment Advisory Commission Oct. 2 on a discussion from the commission’s September meeting on its examination of…
Headline
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a…
Headline
The Department of Health and Human Services Sept. 4 announced that it awarded $11.2 million in grants to 15 recipients across 14 states to develop new…
Headline
The AHA Aug. 28 shared concerns with the Centers for Medicare & Medicaid Services regarding the calendar year 2027 hospital outpatient prospective payment…
Headline
The AHA provided comments to the Centers for Medicare & Medicaid Services Aug. 28 on its calendar year 2027 home health prospective payment system proposed…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…